Piotr Łacina

551 total citations
26 papers, 368 citations indexed

About

Piotr Łacina is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Piotr Łacina has authored 26 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 14 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Piotr Łacina's work include Multiple Myeloma Research and Treatments (8 papers), Immune Cell Function and Interaction (7 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Piotr Łacina is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Immune Cell Function and Interaction (7 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Piotr Łacina collaborates with scholars based in Poland, United Kingdom and Finland. Piotr Łacina's co-authors include Katarzyna Bogunia‐Kubik, Marta Dratwa, Barbara Wysoczańska, Tomasz Kubik, Grzegorz Mazur, Aleksandra Butrym, Justyna Rybka, Rachel E. Crossland, Tomasz Wróbel and Anne M. Dickinson and has published in prestigious journals such as Blood, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Piotr Łacina

22 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Piotr Łacina Poland 10 203 80 76 73 65 26 368
Maria Radanova Bulgaria 12 122 0.6× 52 0.7× 63 0.8× 50 0.7× 199 3.1× 36 424
Daniela Creţu Canada 9 133 0.7× 60 0.8× 74 1.0× 37 0.5× 118 1.8× 27 387
Beatriz Sánchez‐Espiridión United States 13 225 1.1× 25 0.3× 140 1.8× 78 1.1× 79 1.2× 18 475
Farzana L. Walcott United States 11 125 0.6× 49 0.6× 55 0.7× 24 0.3× 33 0.5× 17 295
Ha‐Reum Lee South Korea 13 192 0.9× 25 0.3× 58 0.8× 25 0.3× 81 1.2× 29 372
Marília I. Figueira Portugal 12 158 0.8× 29 0.4× 67 0.9× 12 0.2× 39 0.6× 19 305
Hong Im Kim United States 10 182 0.9× 24 0.3× 51 0.7× 26 0.4× 62 1.0× 15 376
Nandini Ramachandra United States 8 241 1.2× 123 1.5× 68 0.9× 9 0.1× 106 1.6× 15 450
Diane M. Pierson United States 9 111 0.5× 32 0.4× 21 0.3× 30 0.4× 44 0.7× 11 324

Countries citing papers authored by Piotr Łacina

Since Specialization
Citations

This map shows the geographic impact of Piotr Łacina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Łacina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Łacina more than expected).

Fields of papers citing papers by Piotr Łacina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piotr Łacina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Łacina. The network helps show where Piotr Łacina may publish in the future.

Co-authorship network of co-authors of Piotr Łacina

This figure shows the co-authorship network connecting the top 25 collaborators of Piotr Łacina. A scholar is included among the top collaborators of Piotr Łacina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piotr Łacina. Piotr Łacina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Łacina, Piotr, et al.. (2025). Evaluation of polymorphism in BCL-2, PD-1, and PD-L1 genes in myelodysplastic neoplasms. Acta Haematologica Polonica. 56(3). 222–230. 1 indexed citations
2.
Łacina, Piotr, et al.. (2025). Polymorphisms in Necroptosis Pathway Genes: Novel Prognostic Markers for Multiple Myeloma Treatment Outcomes. International Journal of Molecular Sciences. 26(11). 5237–5237.
3.
4.
Salmenniemi, Urpu, Maija Itälä‐Remes, Rachel E. Crossland, et al.. (2024). Donor genetic determinant of thymopoiesis, rs2204985, and stem cell transplantation outcome in a multipopulation cohort. Human Immunology. 85(3). 110791–110791.
5.
Salmenniemi, Urpu, Maija Itälä‐Remes, Rachel E. Crossland, et al.. (2024). Effect of NK cell receptor genetic variation on allogeneic stem cell transplantation outcome and in vitro NK cell cytotoxicity. Scientific Reports. 14(1). 26988–26988. 1 indexed citations
6.
Łacina, Piotr, Anna Czyż, Maria Bieniaszewska, et al.. (2023). Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells. Frontiers in Immunology. 14. 1227897–1227897. 3 indexed citations
7.
Dratwa, Marta, et al.. (2023). Telomere length and hTERT genetic variants as potential prognostic markers in multiple myeloma. Scientific Reports. 13(1). 15792–15792. 4 indexed citations
8.
Łacina, Piotr, Johanna Strobl, Katarzyna Bogunia‐Kubik, et al.. (2023). Complex interactions of cellular players in chronic Graft-versus-Host Disease. Frontiers in Immunology. 14. 1199422–1199422. 9 indexed citations
9.
Wicherska‐Pawłowska, Katarzyna, Katarzyna Bogunia‐Kubik, Piotr Łacina, et al.. (2022). Polymorphisms in the Genes Coding for TLRs, NLRs and RLRs Are Associated with Clinical Parameters of Patients with Acute Myeloid Leukemia. International Journal of Molecular Sciences. 23(17). 9593–9593. 3 indexed citations
10.
Łacina, Piotr, Rachel E. Crossland, Anna Czyż, et al.. (2022). Differential expression of miRNAs from extracellular vesicles in chronic graft-versus-host disease: A preliminary study. Advances in Clinical and Experimental Medicine. 32(5). 539–544. 10 indexed citations
11.
Łacina, Piotr, Aleksandra Butrym, Eliza Turlej, et al.. (2022). BSG (CD147) Serum Level and Genetic Variants Are Associated with Overall Survival in Acute Myeloid Leukaemia. Journal of Clinical Medicine. 11(2). 332–332. 10 indexed citations
12.
13.
Wołowiec, Dariusz, Barbara Wysoczańska, Piotr Łacina, et al.. (2021). NF-κB1 -94del/del ATTG polymorphic variant maintains CLL at an early, mildest stage. Advances in Clinical and Experimental Medicine. 30(5). 499–506.
14.
Dratwa, Marta, Barbara Wysoczańska, Aleksandra Butrym, et al.. (2021). TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia. Scientific Reports. 11(1). 23301–23301. 10 indexed citations
15.
Butrym, Aleksandra, Piotr Łacina, Katarzyna Bogunia‐Kubik, & Grzegorz Mazur. (2021). ABCC3 and GSTM5 gene polymorphisms affect overall survival in Polish acute myeloid leukaemia patients. Current Problems in Cancer. 45(5). 100729–100729. 8 indexed citations
16.
Dratwa, Marta, Barbara Wysoczańska, Piotr Łacina, Tomasz Kubik, & Katarzyna Bogunia‐Kubik. (2020). TERT—Regulation and Roles in Cancer Formation. Frontiers in Immunology. 11. 589929–589929. 200 indexed citations
17.
Bogunia‐Kubik, Katarzyna & Piotr Łacina. (2020). Non‐KIR NK cell receptors: Role in transplantation of allogeneic haematopoietic stem cells. International Journal of Immunogenetics. 48(2). 157–171. 11 indexed citations
18.
Butrym, Aleksandra, Piotr Łacina, Kazimierz Kuliczkowski, Katarzyna Bogunia‐Kubik, & Grzegorz Mazur. (2018). Genetic variation of the gene coding for microRNA-204 (miR-204) is a risk factor in acute myeloid leukaemia. BMC Cancer. 18(1). 107–107. 9 indexed citations
19.
Butrym, Aleksandra, et al.. (2016). Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma. Archivum Immunologiae et Therapiae Experimentalis. 64(S1). 151–156. 11 indexed citations
20.
Butrym, Aleksandra, Justyna Rybka, Piotr Łacina, et al.. (2015). Polymorphisms within beta-catenin encoding gene affect multiple myeloma development and treatment. Leukemia Research. 39(12). 1462–1466. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Radanova Breakdown of academic impact, for papers by Daniela Creţu Breakdown of academic impact, for papers by Beatriz Sánchez‐Espiridión Breakdown of academic impact, for papers by Farzana L. Walcott Breakdown of academic impact, for papers by Ha‐Reum Lee Breakdown of academic impact, for papers by Marília I. Figueira Breakdown of academic impact, for papers by Hong Im Kim Breakdown of academic impact, for papers by Nandini Ramachandra Breakdown of academic impact, for papers by Diane M. Pierson
Rankless by CCL
2026